160 related articles for article (PubMed ID: 8912789)
1. Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours.
Tomlinson IP; Beck NE; Neale K; Bodmer WF
Ann Hum Genet; 1996 Sep; 60(5):369-76. PubMed ID: 8912789
[TBL] [Abstract][Full Text] [Related]
2. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP.
Nimmrich I; Friedl W; Kruse R; Pietsch S; Hentsch S; Deuter R; Winde G; Müller O
Hum Genet; 1997 Sep; 100(3-4):345-9. PubMed ID: 9272153
[TBL] [Abstract][Full Text] [Related]
3. A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36.
Tomlinson IP; Neale K; Talbot IC; Spigelman AD; Williams CB; Phillips RK; Bodmer WF
J Med Genet; 1996 Apr; 33(4):268-73. PubMed ID: 8730279
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
[TBL] [Abstract][Full Text] [Related]
5. Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli.
Spirio LN; Kutchera W; Winstead MV; Pearson B; Kaplan C; Robertson M; Lawrence E; Burt RW; Tischfield JA; Leppert MF; Prescott SM; White R
Cancer Res; 1996 Mar; 56(5):955-8. PubMed ID: 8640784
[TBL] [Abstract][Full Text] [Related]
6. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
Praml C; Amler LC; Dihlmann S; Finke LH; Schlag P; Schwab M
Oncogene; 1998 Oct; 17(15):2009-12. PubMed ID: 9788445
[TBL] [Abstract][Full Text] [Related]
7. Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.
Crabtree MD; Fletcher C; Churchman M; Hodgson SV; Neale K; Phillips RK; Tomlinson IP
Gut; 2004 Feb; 53(2):271-6. PubMed ID: 14724163
[TBL] [Abstract][Full Text] [Related]
8. Exclusion of an extracolonic disease modifier locus on chromosome 1p33-36 in a large Swiss familial adenomatous polyposis kindred.
Plasilova M; Russell AM; Wanner A; Wolf A; Dobbie Z; Müller HJ; Heinimann K
Eur J Hum Genet; 2004 May; 12(5):365-71. PubMed ID: 14735163
[TBL] [Abstract][Full Text] [Related]
9. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM
Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071
[TBL] [Abstract][Full Text] [Related]
10. Human homologue of a candidate for the Mom1 locus, the secretory type II phospholipase A2 (PLA2S-II), maps to 1p35-36.1/D1S199.
Praml C; Savelyeva L; Le Paslier D; Siracusa LD; Buchberg AM; Schwab M; Amler LC
Cancer Res; 1995 Dec; 55(23):5504-6. PubMed ID: 7585622
[TBL] [Abstract][Full Text] [Related]
11. Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis.
Dobbie Z; Müller H; Scott RJ
Hum Genet; 1996 Sep; 98(3):386-90. PubMed ID: 8707313
[TBL] [Abstract][Full Text] [Related]
12. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.
Groves C; Lamlum H; Crabtree M; Williamson J; Taylor C; Bass S; Cuthbert-Heavens D; Hodgson S; Phillips R; Tomlinson I
Am J Pathol; 2002 Jun; 160(6):2055-61. PubMed ID: 12057910
[TBL] [Abstract][Full Text] [Related]
13. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.
Cormier RT; Hong KH; Halberg RB; Hawkins TL; Richardson P; Mulherkar R; Dove WF; Lander ES
Nat Genet; 1997 Sep; 17(1):88-91. PubMed ID: 9288104
[TBL] [Abstract][Full Text] [Related]
14. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers.
Ghorbanoghli Z; Nieuwenhuis MH; Houwing-Duistermaat JJ; Jagmohan-Changur S; Hes FJ; Tops CM; Wagner A; Aalfs CM; Verhoef S; Gómez García EB; Sijmons RH; Menko FH; Letteboer TG; Hoogerbrugge N; van Wezel T; Vasen HF; Wijnen JT
Fam Cancer; 2016 Oct; 15(4):563-70. PubMed ID: 26880076
[TBL] [Abstract][Full Text] [Related]
16. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines.
Haluska FG; Thiele C; Goldstein A; Tsao H; Benoit EP; Housman D
Int J Cancer; 1997 Jul; 72(2):337-9. PubMed ID: 9219842
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
18. Impact of Phospholipase A2 group IIa gene polymorphism on phenotypic features of patients with familial adenomatous polyposis.
Yanaru-Fujisawa R; Matsumoto T; Kukita Y; Nakamura S; Yao T; Hayashi K; Iida M
Dis Colon Rectum; 2007 Feb; 50(2):223-31. PubMed ID: 17164967
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
20. Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes.
Crabtree MD; Tomlinson IP; Hodgson SV; Neale K; Phillips RK; Houlston RS
Gut; 2002 Sep; 51(3):420-3. PubMed ID: 12171967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
